REGENERON PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 900.2 USD | +0.37% |
|
+0.18% | +2.49% |
| Apr. 17 | UBS Adjusts Regeneron Pharmaceuticals Price Target to $1,099 From $1,090, Maintains Buy Rating | MT |
| Apr. 17 | The market is pinning its hopes on earnings reports |  |
Official Publications
| SEC Filing 10K | CO | |
| SEC Filing 8K | CO | |
| Slide show results | CO | |
| Annual results | CO | |
| SEC Filing 8K | CO | |
| SEC Filing 8K | CO | |
| 3rd quarter results | CO | |
| SEC Filing 10Q-3 | CO | |
| Slide show Q3 | CO | |
| Slide show half-year results | CO | |
| 1st-half-year results | CO | |
| SEC Filing 10Q-2 | CO | |
| SEC Filing 8K | CO | |
| Slide show Q1 | CO | |
| SEC Filing 10Q-1 | CO | |
| 1st quarter results | CO | |
| Proxy Statments | CO | |
| Annual ESG Report | CO | |
| SEC Filing 10K | CO | |
| SEC Filing 8K | CO | |
| Slide show results | CO | |
| Annual results | CO | |
| SEC Filing 13G | CO | |
| 3rd quarter results | CO | |
| Slide show Q3 | CO |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Official Publications
